GILD vs TMP
Gilead Sciences Inc (GILD) versus Tompkins Financial Corporation (TMP) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Tompkins Financial Corporation (TMP) is a banks - regional company listed on AMEX.
Latest reported GILD revenue for 2025-12-31 was $29.44B. Net income was $8.51B. Revenue was up 2.4% from 2024-12-31 to 2025-12-31. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported TMP revenue for 2024-12-31 was $79.3M. Net income was $71.0M. Revenue was up 5.7% from 2023-12-31 to 2024-12-31. TMP currently screens at market cap $1.26B and trailing P/E 7.5.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. TMP currently screens at market cap $1.26B and trailing P/E 7.5.
Not investment advice. Open the GILD and TMP stock pages for the full models.
Not investment advice.